Carlsmed (CARL) Depreciation & Amortization (CF) (2024 - 2026)

Carlsmed (CARL) has reported Depreciation & Amortization (CF) for 3 consecutive years, with $130000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Depreciation & Amortization (CF) rose 113.11% year-over-year to $130000.0; the trailing twelve-month figure through Jun 2026 stood at $409000.0 (up 139.18% YoY), and the FY2025 full-year result was $281000.0, up 93.79% from the prior year.
• Depreciation & Amortization (CF) improved to $130000.0 in Q2 2026 per CARL's latest filing, from $99000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $130000.0 in Q2 2026 and bottomed at $33000.0 in Q3 2024.
• Historically, Depreciation & Amortization (CF) has averaged $72500.0 across 3 years, with a median of $71500.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) soared 164.86% in 2025, then surged 113.11% in 2026.
• Over 3 years, Depreciation & Amortization (CF) stood at $37000.0 in 2024, then jumped by 164.86% to $98000.0 in 2025, then jumped by 32.65% to $130000.0 in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $130000.0, $99000.0, and $98000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.